Acarbose is a pseudo-tetrasaccharide produced by biosynthesis, the first drug in the class called alpha-glucosidase inhibitors, aslo the first alpha-glucosidase inhibitor approved by US FDA, developed by Bayer AG。Acarbose was marketed in Germany firstly in July 1984, brand name Glucobay. Acarbose is the top 1 seller in the oral antidiabetic market in China.
The report (2006 edition) represents the import and export status of Acarbose API, production status of Acarbose API in China, sales analysis of Acarbose preparations in China, and the suggestions for marketing. In the report you can know the global output and market size of Acarbose API, market sizes of Acarbose API and preparations in China, the prices, the key manufacturers.
The table of contents
Overview of Acarbose market in China and the global marekt
1 Manufacturers of Acarbose API(Bulk drug)
1.1 Bayer AG
1.2 Chinese enterprises
1.2.1 Sichuan Industrial Institute of Antibiotics Co. Ltd. (SIIA Co.Ltd.)
1.2.2 Hangzhou Huadong Medicine Group Co.,Ltd
1.2.3 Zhejiang Zhebei Pharmaceutical Co.,Ltd.
1.2.4 Zhejiang Hisun Pharmaceutical CO., Ltd
2 Import and export situation of Acarbose API
2.1 Export statistic
2.2 Import statistic
3 Sales analysis of Acarbose preparations in sample hospitals
3.1 Market scale and market shares of different drugs in Chinese market of drugs for regulating blood sugar
3.2 Market shares and growth trend of Acarbose preparations of different enterprises from 2002 to 2005
3.2.1 Bayer AG
3.2.2 Hangzhou Huadong Medicine Group Co.,Ltd
3.2.3 Sichuan Baoguang Pharmaceutical Technology Co., LTD
3.3 Sales analysis in sample cities
3.4 Analysis of other competition breeds
3.4.1 Voglibose
3.4.2 Repaglinide
4 Suggestions for marketing
中文
